# A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

> **NCT01664949** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 460 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Carboxymethylcellulose Based Eye Drop Formulation A
- **DRUG:** Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops

## Key facts

- **NCT ID:** NCT01664949
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 460 (ACTUAL)
- **Last updated:** 2015-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01664949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01664949, "A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01664949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*